Drug and biomarker tissue levels in a randomized presurgical trial on exemestane alternative schedules.
Serrano D, Johansson H, Bertelsen BE, Gandini S, Mellgren G, Thomas P, Crew KD, Kumar NB, Macis D, Aristarco V, Guerrieri-Gonzaga A, Lazzeroni M, D'Amico M, Buttiron-Webber T, Briata IM, Spinaci S, Galimberti V, Vornik LA, Villar-Sanchez E, Brown PH, Heckman-Stoddard BM, Szabo E, Bonanni B, Decensi A.
Serrano D, et al. Among authors: bonanni b.
J Natl Cancer Inst. 2024 Aug 7:djae183. doi: 10.1093/jnci/djae183. Online ahead of print.
J Natl Cancer Inst. 2024.
PMID: 39110531